Covaxin Trial Among Children: Scientists have predicted a third wave of corona virus in the country, in which children may be at greater risk. Meanwhile, a big news is coming in the direction of protecting children from the corona epidemic. The Drug Controller General of India (DCGI) has allowed Bharat Biotech to conduct a clinical trial of its Covid-19 vaccine Covaxin on children between 2 and 18 years of age on Thursday 13 May. Prior to this, Bharat Biotech had asked for permission to trial the vaccine on people aged 2 to 18 years. Currently, after getting the permission of the Drug Controller, the trial will start now.
Trial on 525 healthy volunteers
The Hyderabad-based firm said that Bharat Biotech will test it on 525 healthy volunteers. This will be its second and third phase trial. This decision has been taken after the Subject Expert Committee recommended permission in favor of Bharat Biotech. The government said that permission has been given after careful investigation. It is being told that this test will be done at various places including AIIMS in Delhi and Patna and Meditrina Institute of Medical Sciences, Nagpur.
Drugs Controller General of India (DCGI) approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 years. Bharat Biotech to conduct trials in 525 healthy volunteers pic.twitter.com/ibxAW97bAc
– ANI (@ANI) May 13, 2021
How will the trial
The government said that during the trial, the vaccine will be administered through the muscles in two doses at an interval of 28 days. As a rapid regulatory response, the proposal was discussed in Subject Expert Committee (SEC) (Covid -19) on 11.05.2021. It further stated that after detailed deliberations, the committee had recommended to allow the proposed second and third phase clinical trials with certain conditions.
Children’s vaccination will start in America
The US Food and Drug Administration (FDA), in a major decision, has approved the emergency use of Pfizer-BioNTech COVID Vaccine for children. This vaccine will be given to teenagers i.e. those aged 12-15 years. Vaccination of children between 12 and 15 years of age can start in the US this week. FDA acting commissioner Janet Woodcock called the move an important step in the fight against the Corona epidemic.
Let me tell you that in addition to Pfizer, Moderna is also trialing for the vaccination of children and its results can also be revealed soon. The special thing is that the FDA has expressed confidence in the results of the two companies so far. Another US company NovaVax has a COVID-19 vaccine in its final stages and has also started studying 12 to 17-year-olds.
Get Business News in Hindi, latest India News in Hindi, and other breaking news on share market, investment scheme and much more on Business Khabar. Like us on Facebook, Follow us on Twitter for latest financial news and share market updates.
.